These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 17064823)

  • 1. Influenza vaccine effectiveness among 50-64-year-old persons during a season of poor antigenic match between vaccine and circulating influenza virus strains: Colorado, United States, 2003-2004.
    Herrera GA; Iwane MK; Cortese M; Brown C; Gershman K; Shupe A; Averhoff F; Chaves SS; Gargiullo P; Bridges CB
    Vaccine; 2007 Jan; 25(1):154-60. PubMed ID: 17064823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine--Marshfield, Wisconsin, 2007-08 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(15):393-8. PubMed ID: 18418344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season.
    Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK;
    J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the effectiveness of the 2003-04 influenza vaccine among children and adults--Colorado, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Aug; 53(31):707-10. PubMed ID: 15306754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary assessment of the effectiveness of the 2003-04 inactivated influenza vaccine--Colorado, December 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Jan; 53(1):8-11. PubMed ID: 14724559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.
    Skowronski DM; Masaro C; Kwindt TL; Mak A; Petric M; Li Y; Sebastian R; Chong M; Tam T; De Serres G
    Vaccine; 2007 Apr; 25(15):2842-51. PubMed ID: 17081662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
    Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
    Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficiency of seasonal influenza vaccine in persons older than 65 in Romania. Pilot case-control study I-MOVE, 2008-2009].
    Piţigoi D; Lupulescu E; Alexandrescu V; Băeţel A; Sbârcea C; Ioniţă E; Săvulescu C; Duca E; Sima C; Truică C; Ibram S; Bobîrnac A; Militaru L; Arion M
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):109-16. PubMed ID: 20422925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
    Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
    Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
    Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
    J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza vaccine effectiveness among elderly persons living in the community during the 2003--2004 season.
    Hara M; Sakamoto T; Tanaka K
    Vaccine; 2008 Nov; 26(50):6477-80. PubMed ID: 18573296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis.
    Castilla J; Martinez-Baz I; Martinez-Artola V; Fernandez-Alonso M; Reina G; Guevara M; Garcia Cenoz M; Elia F; Alvarez N; Barricarte A; Ezpeleta C
    Euro Surveill; 2013 Feb; 18(7):2. PubMed ID: 23449182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012.
    King JC; Lichenstein R; Magder LS
    Vaccine; 2013 Jan; 31(5):839-44. PubMed ID: 23219798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection bias in evaluating of influenza vaccine effectiveness: a lesson from an observational study of elderly nursing home residents.
    Fukushima W; Hayashi Y; Mizuno Y; Suzuki K; Kase T; Ohfuji S; Fujieda M; Maeda A; Hirota Y
    Vaccine; 2008 Nov; 26(50):6466-9. PubMed ID: 18582520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
    Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
    J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05.
    Müller D; Szucs TD
    Infection; 2007 Oct; 35(5):308-19. PubMed ID: 17885730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using surveillance to evaluate influenza vaccine effectiveness.
    Jackson LA
    J Infect Dis; 2009 Jan; 199(2):155-8. PubMed ID: 19086916
    [No Abstract]   [Full Text] [Related]  

  • 18. Influenza vaccine: the challenge of antigenic drift.
    Carrat F; Flahault A
    Vaccine; 2007 Sep; 25(39-40):6852-62. PubMed ID: 17719149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effectiveness of triennial anti-influenza vaccination in French military during the 2003-2004 influenza season].
    Haus-Cheymol R; Nicand E; Buisson Y; Berger F; Decam C; Spiegel A;
    Rev Epidemiol Sante Publique; 2007 Oct; 55(5):339-45. PubMed ID: 17870268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012.
    Jimenez-Jorge S; de Mateo S; Pozo F; Casas I; Garcia Cenoz M; Castilla J; Gallardo V; Perez E; Vega T; Rodriguez C; Quinones C; Martinez E; Gimenez J; Vanrell J; Castrillejo D; Serrano M; Ramos J; Larrauri A
    Euro Surveill; 2012 Mar; 17(12):. PubMed ID: 22490308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.